{"entity":{"type":"insider","cik":"0002022156","url":"/insider/0002022156","json_url":"/insider/0002022156.json","name":"Yeleswaram Krishnaswamy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2026-01-05","last":"2026-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Yeleswaram Krishnaswamy","source":"filing","n_filings":6,"first_seen":"2026-01-05","last_seen":"2026-08-20"}],"transactions":[{"id":9299274,"accession":"0001193125-26-359189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-359189","line_url":"/filing/0001193125-26-359189#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":404.0,"shares_display":"404","price_per_share":49.9,"price_display":"49.90","price_state":"stated","total_value":20159.6,"total_display":"20,159.60","total_whole":"20,160","shares_owned_after":246022.0,"shares_owned_after_display":"246,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"insider"},{"id":5785130,"accession":"0001193125-26-167091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-167091","line_url":"/filing/0001193125-26-167091#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20225.0,"shares_display":"20,225","price_per_share":39.9923,"price_display":"39.99","price_state":"stated","total_value":808844.2675,"total_display":"808,844.27","total_whole":"808,844","shares_owned_after":246426.0,"shares_owned_after_display":"246,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-21","scope":"insider"},{"id":5930063,"accession":"0001193125-26-154908","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-154908","line_url":"/filing/0001193125-26-154908#line-3","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10200.0,"shares_display":"10,200","price_per_share":35.0781,"price_display":"35.08","price_state":"stated","total_value":357796.62,"total_display":"357,796.62","total_whole":"357,797","shares_owned_after":266651.0,"shares_owned_after_display":"266,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-14","filed_date":"2026-04-14","scope":"insider"},{"id":5930062,"accession":"0001193125-26-154908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-154908","line_url":"/filing/0001193125-26-154908#line-2","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9165.0,"shares_display":"9,165","price_per_share":34.974,"price_display":"34.97","price_state":"stated","total_value":320536.71,"total_display":"320,536.71","total_whole":"320,537","shares_owned_after":276851.0,"shares_owned_after_display":"276,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-13","filed_date":"2026-04-14","scope":"insider"},{"id":5930060,"accession":"0001193125-26-154908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-154908","line_url":"/filing/0001193125-26-154908#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":34.98,"price_display":"34.98","price_state":"stated","total_value":17490.0,"total_display":"17,490.00","total_whole":"17,490","shares_owned_after":286016.0,"shares_owned_after_display":"286,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-10","filed_date":"2026-04-14","scope":"insider"},{"id":5905230,"accession":"0001193125-26-149725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-149725","line_url":"/filing/0001193125-26-149725#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360.0,"shares_display":"360","price_per_share":34.9,"price_display":"34.90","price_state":"stated","total_value":12564.0,"total_display":"12,564.00","total_whole":"12,564","shares_owned_after":286516.0,"shares_owned_after_display":"286,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider"},{"id":5979316,"accession":"0001193125-26-126410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-126410","line_url":"/filing/0001193125-26-126410#line-1","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10115.0,"shares_display":"10,115","price_per_share":29.9906,"price_display":"29.99","price_state":"stated","total_value":303354.919,"total_display":"303,354.92","total_whole":"303,355","shares_owned_after":286876.0,"shares_owned_after_display":"286,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-26","scope":"insider"},{"id":6228125,"accession":"0001193125-26-002469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-002469","line_url":"/filing/0001193125-26-002469#line-2","is_derivative":false,"issuer_cik":"0002012593","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0002012593","owner_cik":"0002022156","owner_name":"Yeleswaram Krishnaswamy","owner_display_name":"Yeleswaram Krishnaswamy","owner_url":"/insider/0002022156","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2840.0,"shares_display":"2,840","price_per_share":30.05,"price_display":"30.05","price_state":"stated","total_value":85342.0,"total_display":"85,342.00","total_whole":"85,342","shares_owned_after":296991.0,"shares_owned_after_display":"296,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-31","filed_date":"2026-01-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002012593","name":"Rapport Therapeutics, Inc.","url":"/issuer/0002012593","role":"Officer (Chief Development Officer)","n_filings":6,"first_seen":"2026-01-05","last_seen":"2026-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002022156","retrieved_at":"2026-08-25T15:54:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}